Published • loading... • Updated
Centre Bans 16 Fixed-Dose Drug Combinations, Citing Public Health Concerns
A scientific review found the combinations lacked therapeutic value and could pose public health risks, the Health Ministry said.
- On Saturday, the Union Health Ministry prohibited the manufacture, sale, and distribution of 16 fixed-dose combination drugs, stating they "lack therapeutic justification" and are "not considered beneficial" regarding potential health risks.
- This action stems from a Supreme Court-mandated review of the Indian drug market, where the Drugs Technical Advisory Board formed an expert committee to identify irrational or potentially harmful formulations.
- Prohibited formulations span various therapeutic categories, including antibiotic-based combinations like Amoxicillin with Serratiopeptidase and dermatological preparations containing Aloe Vera, plus analgesic and antispasmodic medicines combining Dicyclomine and Paracetamol.
- All state drug controllers and enforcement agencies received directives to ensure strict implementation of the ban, requiring manufacturers, importers, and distributors to take necessary corrective measures immediately.
- The decision aligns with the government's broader effort to promote rational medicine use and ensure only scientifically validated drugs remain available, building on similar actions taken in previous years.
Insights by Ground AI
18 Articles
18 Articles
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources18
Leaning Left2Leaning Right4Center1Last UpdatedBias Distribution57% Right
Bias Distribution
- 57% of the sources lean Right
57% Right
L 29%
14%
R 57%
Factuality
To view factuality data please Upgrade to Premium
